Geneva Capital Management’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
CIP
ACH
Geneva Capital Management's OMCL Position: Q3 2024 in Review
Geneva Capital Management sold out of Omnicell (OMCL) in Q3 2024, closing a stake of 621,679 shares — an estimated $16.8M sold.
Geneva Capital Management first reported a position in OMCL in Q1 2020 and held it in 18 quarters. The position peaked at $153M in Q4 2021. 259 funds tracked by Wall St. Rank hold OMCL as of Q3 2024.
- Geneva Capital Management reported no remaining Omnicell position as of Q3 2024 after selling out during the quarter.
- Geneva Capital Management sold 621,679 Omnicell shares in Q3 2024, an estimated $16.8M.
- Geneva Capital Management first reported a position in Omnicell in Q1 2020 and held it in 18 quarters.
- Geneva Capital Management's Omnicell position peaked at $153M in Q4 2021.
- 259 funds tracked by Wall St. Rank held Omnicell as of Q3 2024.
Based on Geneva Capital Management's 13F filing for Q3 2024, filed 5 Nov 2024.